CKPT: Checkpoint Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 153.78
Enterprise Value ($M) 149.08
Book Value ($M) -12.59
Book Value / Share -0.28
Price / Book -12.21
NCAV ($M) -12.59
NCAV / Share -0.28
Price / NCAV -12.21

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -20.95
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.29
Current Ratio 0.29

Balance Sheet (mrq) ($M)
Current Assets 5.18
Assets 5.18
Liabilities 17.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-14 13G/A Armistice Capital, Llc 9.99 68.42
10-01 13D/A Fortress Biotech, Inc. 9.80 3.41

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐TRANSITION REPORT
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one)
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one)
2024-03-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-22 177,332 822,441 21.56
2024-11-21 93,566 468,213 19.98
2024-11-20 147,120 545,257 26.98
2024-11-19 109,222 356,439 30.64
2024-11-18 235,842 754,505 31.26

(click for more detail)

Similar Companies
CELZ – Creative Medical Technology Holdings, Inc. CGEN – Compugen Ltd.
CING – Cingulate Inc. CLDX – Celldex Therapeutics, Inc.
CLNN – Clene Inc.


Financial data and stock pages provided by
Fintel.io